NICORYA SCOTT: Open Payments
NPI 1073270609 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,020 in 9 payments from 7 companies in 2025. Trend: 2023 $2,756 · 2024 $737 · 2025 $1,020
Food & beverage: $1,020
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $255 |
| JAZZ PHARMACEUTICALS INC. | 2 | $247 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $134 |
| Alexion Pharmaceuticals, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Eisai Inc. | 1 | $94 |
| Boston Scientific Corporation | 1 | $45 |
Products named: REZDIFFRA, EPIDIOLEX, Kerendia, ULTOMIRIS, BENLYSTA, Leqembi, ACCOLADE SR.
Industry payments across MI — which companies pay providers there.
